Press release: A very exciting partnership

Thursday, 23 January 2020

We are delighted to announce that the International Alliance of Patients Organizations (IAPO) and Upjohn, a Pfizer division have signed a letter of intent to work together to build a sustainable patient-centred approach towards the care of non-communicable diseases (NCD).

Through this partnership, we will establish a framework for cooperation and work together to understand the patient voice, explore advocacy opportunities and amplify the impact along the patient journey. The partnership will also pursue collaborative opportunities that would benefit and leverage the missions of both organizations.

“We cannot overcome the burden of NCDs alone”. The patients’ lived experience and journey is not linear said Dr Ratna Devi, Chair of the Board of Trustees, IAPO, “Upjohn is focused on NCDs and to our delight understands the complexities of this journey. We are thrilled to partner with Upjohn to further our advocacy of the patient voice along their NCD journey”

International Alliance of Patients’ Organizations (IAPO)

The vision of IAPO is to see patients at the centre of healthcare throughout the world. Our mission is to help build patient-centred healthcare worldwide. Everything IAPO does is focused on promoting patient-centred healthcare. IAPO strives to be the global voice for people who suffer from any disease, disability, illness, impairment or syndrome, and by being the focal point for patients’ organizations around the world.
We do this by: 
Actively working with patients' organizations and building them up to be as effective as possible
Advocating internationally with a strong patients' voice on relevant aspects of healthcare policy, with the aim of influencing international, regional and national health agendas and policies 
Building cross-sector alliances and working collaboratively with like-minded medical and health professionals, policy makers, academics, researchers and industry representatives 

Upjohn, a Pfizer division

The mission of Upjohn, A Pfizer Division is to relieve the burden of NCDs with trusted, quality medicines for every patient, everywhere. Inspired by the heritage of a company known for its pioneering science, Upjohn harnesses the power of 20 of Pfizer's most iconic established biopharmaceutical brands – across therapeutic areas including cardiovascular, pain, psychiatry, and urology – by thinking strategically and operating nimbly. We seek to leverage our portfolio, experience and expertise to become the trusted partner of choice to all stakeholders committed to improving patient health.